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Abstract
Background:  Mammary gland development culminates in lactation and is orchestrated by
numerous stimuli and signaling pathways. The Src family of nonreceptor tyrosine kinases plays a
pivotal role in cell signaling. In order to determine if Src plays a role in mammary gland development
we have examined mammary gland development and function during pregnancy and lactation in
mice in which expression of Src has been eliminated.
Results: We have characterized a lactation defect in the Src-/- mice which results in the death of
over 80% of the litters nursed by Src-/- dams. Mammary gland development during pregnancy
appears normal in these mice; however secretory activation does not seem to occur. Serum
prolactin levels are normal in Src-/- mice compared to wildtype controls. Expression of the
prolactin receptor at both the RNA and protein level was decreased in Src-/- mice following the
transition from pregnancy to lactation, as was phosphorylation of STAT5 and expression of milk
protein genes. These results suggest that secretory activation, which occurs following parturition,
does not occur completely in Src-/- mice. Failed secretory activation results in precocious
involution in the mammary glands of Src-/- even when pups were suckling. Involution was
accelerated following pup withdrawal perhaps as a result of incomplete secretory activation. In
vitro differentiation of mammary epithelial cells from Src-/- mice resulted in diminished production
of milk proteins compared to the amount of milk proteins produced by Src+/+ cells, indicating a
direct role for Src in regulating the transcription/translation of milk protein genes in mammary
epithelial cells.
Conclusion: Src is an essential signaling modulator in mammary gland development as Src-/- mice
exhibit a block in secretory activation that results in lactation failure and precocious involution. Src
appears to be required for increased expression of the prolactin receptor and successful
downstream signaling, and alveolar cell organization.
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Background
The mammary gland is a unique organ in that develop-
ment primarily takes place postnatally. During puberty,
primarily under the influence of estrogen, ductal elonga-
tion and branching occurs to form the primary ductal tree
[1-3]. At the onset of pregnancy, progesterone and prolac-
tin stimulate the outgrowth of both lateral and alveolar
buds resulting in the formation of secretory lobuloalveo-
lar units [4-6]. During lactation these lobuloalveolar units
produce and secrete the milk needed to sustain the viabil-
ity and growth of newborn pups. At parturition there is a
dramatic increase in the expression of milk protein genes
and lipid biosynthetic enzymes [7,8]. The transition from
late pregnancy to lactation is referred to as secretory acti-
vation [9,10], and this transition is stimulated by a rise in
prolactin (PRL) and decrease in serum progesterone [11-
14]. While the molecular mechanisms underlying secre-
tory activation remain obscure, the expression of several
signaling molecules and transcription factors increases at
this time, including Src (Richert et al, unpublished data),
Akt [7,8,15], Elf5 [16], and sterol response element bind-
ing protein (SREBP) [7,8]. Each of these factors may play
either unique or redundant roles in secretory activation.
Copious production of milk during lactation is stimulated
by PRL, which induces expression of milk protein genes
and maintains viability of the mammary epithelial cells
[17-19]. The role of PRL in regulating lipid biosynthesis
by mammary epithelial cells is less well established, and
is likely to be heavily influenced by the diet of the mouse
[8,10]. Upon weaning of the pups, the mammary gland
undergoes involution: involution is characterized by the
apoptosis of the majority of the mammary epithelial cells
and degradation/remodeling of the extracellular matrix by
matrix metalloproteases (MMPs) resulting in ductal struc-
tures that closely resemble those present in the virgin
mouse [20].
Src is the prototype of the Src family of nonreceptor pro-
tein tyrosine kinases, a family that includes eight closely
related members which share common structural motifs
[Src, Fyn, Yes, Fgr, Lyn, Lck, Hck, and Blk] [21]. The acti-
vation of this family of protein kinases is regulated by
interaction of either the SH2 or SH3 domains of Src family
kinases with specific ligands that results in structural
changes leading to catalytic activation of the kinase
domain [22,23]. Src family kinases can be activated by
stimulation of cells with peptide growth factors [24-26],
steroid hormones [27-29], and through engagement of
integrins by binding to extracellular matrix [30]. Thus Src
family kinases appear to be a central node in signaling by
numerous receptor complexes. Since mammary gland
development and function is regulated by all of these
stimuli (peptide growth factors, steroid receptors and
integrins), we expected that mammary gland develop-
ment and/or function might be disrupted in mice lacking
expression of Src. It has been observed that mammary
gland development during puberty is altered in the Src-/-
mice [31] (Richert et al, unpublished data) such that duc-
tal elongation is delayed in Src-/- mice compared to
wildtype Src+/+ mice. Mechanisms that may underlie the
delay in ductal elongation include changes in estrogen
receptor signaling or a change in the amount of estrogen
receptor [31], or a requirement for expression of Src in the
stromal cell compartment of the mammary gland (Richert
et al, unpublished data). While conducting these studies
we also observed that Src-/- mice display many aspects of
a lactation failure including death of most of the pups and
retarded growth of any surviving pups. In this manuscript
we report that Src is required for the induction of lactation
and Src-/- mice exhibit a block in secretory activation that
results in lactation failure, death of newborn pups, and
precocious involution.
Results
Src deficient mice have normal pregnancy-induced 
development
Mammary gland development occurs in defined stages
that are linked to sexual development and reproduction.
Src is required for ductal elongation during pubertal
development of the mammary gland [31] (Richert et al,
unpublished data). Gene expression analysis and immu-
noblot analysis demonstrates that expression of Src
increases late in pregnancy during the transition from
pregnancy to lactation (Richert et al, unpublished data), a
transition referred to as secretory activation [9,10,32]. The
expression of Src in the mammary gland during pregnancy
and lactation was examined by immunoblot analysis of
whole mammary gland lysates harvested at day eighteen
of pregnancy and days two and nine of lactation (Figure
1). Src protein expression was detected at all three of these
stages in lysates prepared from Src+/+ mice, although the
amount of Src protein is lower at day nine of lactation
compared to day two of lactation. While there is some var-
iation between the three different animals shown at each
time point, the general trend is clear; there is an increase
in the amount of Src between day eighteen of pregnancy
(P18) and day two of lactation (L2), followed by a
decrease in the amount of Src protein by day nine of lac-
tation (L9) (Figure 1, middle panel, lanes 4–6, 10–12 and
16–18). No Src was detected in lysates of glands harvested
from Src-/- mice (Figure 1, middle panel, lanes 1–3, 7–9
and 13–15). To examine the catalytic activation of Src,
protein lysates were immunoblotted with an anti-phos-
pho-Src antibody that specifically detects Src family mem-
bers when phosphorylated on tyrosine416 in the activation
loop of the kinase (Figure 1, top panel). Phosphorylation
of tyrosine416, which correlates with the catalytic activa-
tion of Src, was apparent in lysates prepared from the
mammary glands of wildtype mice at P18, L2, and L9 (Fig-
ure 1, top panel, lanes 4–6, 10–12 and 16–18). AlthoughBMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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most of the lysates isolated from Src-/- mice do not appear
to react with the anti-phospho-Src tyrosine416 antibody,
immunoreactive material is detected in several of the sam-
ples (Figure 1, top panel, lanes 3, 14 and 15). The anti-
phospho- Src tyrosine416 antibody is not specific for Src
and is able to recognize the same phosphorylation site in
the activation loop in Fyn, Lyn, Lck, Yes, and Hck; of these
Src family members only Fyn is expressed in high levels in
the mammary gland (Richert et al, unpublished data)
[33]. Therefore we believe that this band represents acti-
vated Fyn in these samples, although we have not directly
demonstrated this by immunoprecipitation of Fyn from
these samples. Each lane represents tissue lysates har-
vested from different animals, and it would be expected
that there might be animal-to-animal variations in the
expression and activation of Src. The fact that Src is
expressed and is activated during late pregnancy and lac-
tation stimulated us to determine whether it plays a role
in the complex signaling events that occur within the
mammary epithelial cell during this developmental
phase.
Mammary gland development during pregnancy is char-
acterized by the formation of secondary branches and
extensive lobuloalveolar development, and results in a
dramatic increase in the number of mammary epithelial
cells in the mammary gland; based upon the expression
levels of keratin-19 and claudin 7, there is a 1000-fold
increase in the number of epithelial cells by the end of
pregnancy, although when the volume of epithelial cells is
considered, a 125-fold increase might be considered to be
a more conservative estimate [34]. This phase of mam-
mary gland development is primarily driven by progester-
one [6,35]. Whole mounts of mammary glands from Src
knockout animals from days six (P6), twelve (P12) and
eighteen (P18) of pregnancy demonstrate that at P6 the
density of ducts, the extent of ductal branching and alve-
olar bud formation in Src-/- mice was reduced compared
to both Src+/+ and Src+/- mice (Figure 2, panel C com-
pared to A and B). By P18, however, there appeared to be
no difference in mammary gland development between
Src+/+, Src+/-, and Src-/- mice (Figure 2, panels G, H and
I). The density of the epithelial structures in the Src-/- mice
appeared similar to glands from Src+/+ mice on day eight-
een of pregnancy (Figure 2, panels G and I). Thus the
whole mounts indicate that by the end of pregnancy duc-
tal density and lobuloalveolar development in the Src-/-
mice is normal (Figure 2, panels G-I). Examination of
hematoxylin and eosin stained thin sections of mammary
glands isolated from Src+/+, Src+/- and Src-/- mice on P18
also demonstrate that pregnancy-induced development in
the Src-/- mice is normal, with prominent densely-stain-
ing secretory alveoli surrounded by adipocytes visualized
in all three genotypes examined (Figure 2, panels J, K and
L). Therefore we conclude that the diminished ductal
branching and density observed at P6 may reflect the
Src is expressed and activated in wildtype mammary glands during pregnancy and lactation Figure 1
Src is expressed and activated in wildtype mammary glands during pregnancy and lactation. The number 4 mam-
mary gland was removed from Src-/- and Src+/+ mice on day 18 of pregnancy (P18) (lanes 1–6), lactation day 2 (L2) (lanes 
7–12), and lactation day 9 (L9) (lanes 13–18). Three separate mice were used per genotype and developmental stage. Protein 
lysates were prepared as described in the Materials and Methods sections, and immunoblotting conducted to detect phospho-
rylated Src (tyrosine416) (top panel), total Src (middle panel), total actin, as a loading control (bottom panel).BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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reduced ductal density and delayed mammary gland
development observed in 10 week-old virgin Src-/- mice
[31] (Richert et al, unpublished data), as mice of this age
were used in these studies, rather than decreased prolifer-
ation of mammary epithelial cells during pregnancy.
Pups suckled by Src knockout mice have significantly 
reduced weight gain
Secretory activation occurs following parturition and
leads to the production of copious amounts of milk
required to nourish pups. The first indication that Src is an
important mediator of mammary gland development was
observed when the Src knockout mice were unable to sup-
port growth and survival of their pups. The litters born to
Src-/- dams were small and over 90% of the pups died
within three days. In order to assess the apparent lactation
failure of the Src-/- mice, average pup weights during the
first 9 days of lactation were measured. The pups from the
Src-/- mice were replaced with eight newborn pups from
wildtype FVB, C57Bl6, or Src+/- mothers (Figure 3, panels
A, B and C, respectively). Due to the poor growth and
recurrent death of these foster pups, resulting in the death
of over 80% of the fostered litters, we also tried replacing
the pups of the Src-/- dams with older pups that were
"experienced" at nursing. In the course of the experiments
to characterize the lactation potential of the Src-/- dams
only three fostered litters nursed by the Src-/- dams sur-
vived. The pups in each of these three litters had reduced
weight gain over the nine days of lactation analyzed com-
pared to litters nursed by control mothers (Figure 3). In
Figure 3A eight newborn FVB pups were nursed by a Src-/
- mouse. For the first few days the FVB pups showed very
Src deficient mice have normal pregnancy-induced development Figure 2
Src deficient mice have normal pregnancy-induced development. Whole mounts of the number 2 and 3 mammary 
gland of Src+/+ (A, D, G, and J), Src+/- (B, E, H and K) and Src-/- (C, F, I and L) mice at P6 (A-C), P12 (D-F) and P18 (G-I). His-
tological sections from mammary glands at P18 are also shown for each genotype (J-L). In panels A to I scale bars represent 5 
mm. In panels J to L scale bars represent 100 μm.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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little weight gain then after day 4 their weight steadily
increased and after nine days of lactation the average pup
weight was 2.8 grams, which is much reduced compared
to the 4.7 grams for FVB pups nursed by an FVB mother
(Figure 3A). When eight day old C57Bl6 pups were cross-
fostered onto a Src-/- mouse, in Figure 3B, the growth of
these pups was severely diminished compared to those
nursed by control dams (Figure 3B). Indeed on day 16,
when the cross-fostered pups had been nursed by the Src-
/- mouse for 9 days, the average pup weight was 3.7 grams
compared to 5.8 grams for the control C57Bl6 pups
nursed by a C57Bl6 dam. The 6 day old pups from a Src+/
- litter that were fostered by the Src-/- mouse in Figure 3C
demonstrated the least detrimental effect on their growth.
When they were 9 days old (day 4 of lactation for the Src-
/- mouse) the average pup weight was 3.7 grams com-
pared to 4.5 grams for those nursed by Src+/- dams. For
each of these studies the growth of pups nursed by Src-/-
dams was compared to 3 litters of pups nursed by control
dams (FVB, C57Bl6 and Src+/-). Due to the high mortality
of pups nursed by Src-/- dams there were no additional lit-
ters to include in this analysis. These results demonstrate
that Src knockout mice have diminished lactation capacity
regardless of the strain or genotype of the pups nursed and
therefore support the conclusion that Src is essential for
secretory activation and/or lactation.
Altered mammary gland histology during lactation 
suggests lactation failure in Src-/- mice
As described above, the mammary glands of Src-/- mice
appeared similar to those of Src+/+ and Src+/- mice at P18
with prominent densely-staining secretory alveoli sur-
rounded by adipocytes. By day 2 of lactation (L2) the
luminal space of the alveoli from Src+/+ and Src-/- mice
had expanded and are clearly evident due to the layer of
densely staining mammary epithelial cells that surround
the lumen (Figure 4, panels A and B). The mammary epi-
thelial cells of the Src-/- mice have an abundance of large
lipid droplets that are not present in mammary epithelial
cells from Src+/+ or Src+/- mice, this observation was fur-
ther investigated (See Figure 5 and below).
By L9 the normal mammary gland is producing copious
amounts of milk, approximately 4.5–5 ml/day/dam [36].
The histology of the mammary gland at this time point
reflects the expansion of lactation and it is generally char-
acterized by the presence of fully expanded lumens sur-
rounded by a densely staining layer of mammary
epithelial cells [37]. The mammary glands of both the
Src+/+ and Src+/- mice were similar and displayed the nor-
mal morphology expected in lactating mice at this time
point [37] (Figure 4, panel C and data not shown). In con-
trast two different morphologies were observed in the
mammary glands of Src-/- mice; in one of the three mice
shown in Figure 4, the structure of the mammary gland
Pups suckled by Src knockout mice have dramatically  reduced weight gain Figure 3
Pups suckled by Src knockout mice have dramatically 
reduced weight gain. Graphs demonstrating the weight 
gain of pups foster nursed by Src-/- mice compared to the 
weight gain of pups nursed by control dams. Litters were 
normalized to eight pups. N = 3 for the control mice and 
error bars depict the s.e.m. in the growth of these control 
litters. The start of each graph represents day 1 of lactation 
(first day post-partum) for the nursing mother. The weights 
of pups nursed by Src-/- mice were recorded for 9 days. A) 
Weight gain of a single litter of eight newborn FVB pups fos-
tered by Src-/- mouse in comparison to three litters of FVB 
pups nursed by FVB dams. B) Weight gain of a single litter of 
eight C57Bl6 pups that were 8 days old when they were 
cross-fostered onto a Src-/- mouse that was one day post-
partum. The growth rate is compared to three litters of 
C57Bl6 pups nursed by control C57Bl6 dams. C) Weight gain 
by a single litter of 6-day old Src+/- pups cross-fostered onto 
a Src-/- mouse that was one day post-partum in comparison 
to three litters nursed by Src+/- dams.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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appeared to be similar to that seen in wildtype (Figure 4),
however the mammary glands of the two other Src-/- mice
have the morphology expected of a mammary gland that
is undergoing involution (Figure 4, panels D and E). In
both of these mammary glands the secretory alveoli have
collapsed (Figure 4, panels D and E), and a large dis-
tended duct that is filled with milk proteins, lipid droplets
and apoptotic cells is readily apparent in one of the mice
examined (Figure 4, panel D). When compared to the his-
tology of an involuting mammary gland from normal
mice, the morphology observed in Figure 4, panel D is
typical of what would be expected on day four of involu-
tion, while the morphology observed in Figure 4, panel E
is typical of a mammary gland on day six to eight of invo-
lution when extensive remodeling of the gland has
occurred [37]. In all of the cases shown in panels D-F of
Figure 4, the dams were nursing pups and thus were con-
sidered to be "lactating". In the course of our experiments
we have observed that one out of six Src-/- mice exhibits
histology similar to that observed in the mammary gland
of a wildtype gland at lactation day 9. The mammary
glands of the five remaining Src-/- mice displayed histol-
ogy typically seen in mammary glands undergoing involu-
tion, and the morphology observed varied from that
normally seen on day two of involution to that seen on
day eight of involution. Our observation that one of six
Src-/- mice has a normal histology at L9 is consistent with
the observation that 3 out 16 mice were able to sustain
growth of foster pups over this time period, although at a
reduced rate (Figure 3).
Secretory activation does not occur in Src-/- mice following 
parturition
The decrease in the concentration of progesterone that
occurs immediately prior to parturition combined with
the increased concentration of PRL that occurs late in
pregnancy, and the PRL that is released by the pituitary in
response to suckling, are required for secretory activation
[14,38]. Characteristically mammary epithelial cells from
late pregnant mice have large cytoplasmic lipid droplets
(CLDs) that are often centrally located within the cell
[37]. Following parturition only small lipids droplets are
observed at the luminal surface of mammary epithelial
cells; a change that is thought to reflect secretory activa-
tion of cells in the alveolus [10] (T. Russell and J.L.
McManaman, unpublished data). At L2 mammary epithe-
lial cells from Src+/+, and Src+/- mice have small lipid
droplets at their apical surface (Figure 5, C, and 5F), while
mammary epithelial cells from Src-/- mice have large, cen-
trally located lipid droplets (Figure 5I). To further exam-
ine the induction of secretory activation following
parturition, sections of mammary gland from Src+/+,
Src+/- and Src-/- mice were stained with rabbit anti-adi-
pocyte differentiation-regulated protein, also known as
adipophilin (ADPH), which is present in the outer mem-
brane of cytoplasmic lipid droplets (CLDs) The luminal
surfaces of secretory alveoli were visualized with Oregon-
Green 488-conjugated wheat germ agglutinin (WGA), and
the nuclei were stained with DAPI (Figure 5, A, B, D, E, G
and 5H). Secretory alveoli of Src+/+ mice on day eighteen
of pregnancy were readily apparent by the circle of DAPI-
stained nuclei deposited around the luminal surface of the
Altered mammary gland histology during lactation suggests lactation failure in Src-/- mice Figure 4
Altered mammary gland histology during lactation suggests lactation failure in Src-/- mice. Histological sections 
from the mammary glands of Src+/+ (A and C) and Src-/- (B and D-F) at L2 (A-B), and L9 (C-F). Three sections of mammary 
glands from Src-/-mice are shown at L9 (D-F). Scale bars represent 100 μm.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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alveolus, which was stained with WGA (Figure 5A, lumi-
nal space is labeled L). Mammary epithelial cells from
Src+/+ mice at P18 contained large lipid droplets that are
outlined red by ADRP staining (Figure 5A, white arrow-
heads). By L2 the luminal space has expanded considera-
bly and the lipid droplets are smaller in size and primarily
deposited along the luminal surface of the cells (Figure
5B, white arrowhead). Staining of P18 mammary glands
from Src-/- dams in an identical manner revealed poorly
organized secretory alveoli with disordered lumen as evi-
denced by the unorganized pattern of staining with WGA
(Figure 5G, white arrow). Large CLDs were apparent in
Src-/- mammary gland sections at P18 based upon anti-
APDH staining (Figure 5G, white arrowhead). Luminal
spaces were more evident when the structure of the secre-
tory alveoli from Src-/- mice at L2 were examined, how-
ever, some mammary epithelial cells stained on multiple
surfaces with WGA and these cells contained large CLDs
(Figure 5H). These observations suggest that Src is
required for the structural organization of mammary epi-
Secretory activation does not occur in Src-/- mice following parturition Figure 5
Secretory activation does not occur in Src-/- mice following parturition. Histological sections were prepared from 
the mammary glands of Src+/+ (A-C), Src+/- (D-F), and Src-/- (G-I) mice at P18 (A, D, and G) and L2 (B, C, E, F, H and I). The 
sections shown in A, B, D, E, G and H were stained anti-ADRP antibody to outline the cytoplasmic lipid droplets (red), Ore-
gon-Green 488-conjugated WPA to outline the surface of secretory alveoli (green), and DAPI to stain the nuclei of mammary 
epithelial cells (blue). Hematoxylin and eosin-stained sections of mammary glands at L2 are shown in C, F, and I. The bar in 
panel H represents 10 μm and the bars in panels C, F and I represent 100 μm. Luminal space is indicated by the letter "L", the 
white arrowheads indicate cytoplasmic lipid droplets, and the white arrows indicates regions where staining with WGA repre-
sents atypical patterns not observed in wildtype mice. The black arrows in panel I indicate large cytoplasmic lipid droplets not 
observed in wildtype mice.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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thelial cells into secretory lobuloalveolar units. The lack of
Src expression results in large CLDs persisting in the mam-
mary epithelial cells at L2, indicating that secretory activa-
tion has not occurred. Mammary glands from Src+/- mice
have an intermediate phenotype at P18. Organized lobu-
loalveolar structures are apparent, however, unorganized
alveoli are also evident, as are alveoli with WGA staining
between cells (Figure 5D, white arrows). By L2, the mam-
mary gland structure in the Src+/- mice appeared to be
largely normal with expanded luminal spaces and small
lipid droplets (Figure 5E). This indicates that although
lobuloalveolar development may be somewhat disorgan-
ized in Src+/- mice late in pregnancy, secretory activation
post-partum occurs normally and that by L2, the mam-
mary gland exhibits the normal structure of a lactating
mammary gland.
Serum prolactin levels are not altered in Src-/- mice, 
however expression of the prolactin receptor is diminished
The hormone PRL was first identified by its ability to stim-
ulate mammary gland development and lactation in rab-
bits and it has since been demonstrated as an essential
modulator of proliferation and differentiation of alveoli
during pregnancy and milk protein expression during lac-
tation [39-41]. Due to the critical role of PRL in lactogen-
esis, the amount of serum PRL in Src+/+, Src+/- and Src-/-
mice was quantitated to determine whether a reduction in
serum PRL could account for the lactation failure in Src-/-
mice. Serum PRL was determined in five Src+/+, Src+/-
and Src-/- mice at P17 and L2 and were found to be com-
parable in both the Src+/+ and Src-/- mice (Figure 6A)
thus eliminating diminished serum PRL as the mecha-
nism underlying the observed lactation failure in Src-/-
mice. It is interesting to note that serum PRL levels were
elevated in the Src+/- mice at both times examined, how-
ever the increase is not significant.
Since serum PRL levels in the Src-/- mice were similar to
those detected in Src+/+ mice we then pursued the
hypothesis that the phenotype of the Src-/- mice may
result from a block in PRL action. PRL action requires
binding to its cognate receptor, the PRL receptor (PRLR).
To determine if expression of the PRLR is altered in the
Src-/- mice, PRLR levels were examined by quantitative
RT-PCR and immunoblotting with an anti-PRLR anti-
body. The message for the long isoform of the PRLR
increased in the mammary glands of wild type mice dur-
ing lactation, peaked at L9, and then declined by day two
of involution. This pattern of expression for the long form
of the PRLR during mammary gland development is con-
sistent with previous data [7,8,42]. However, no increase
in the levels of mRNA encoding the long form of the PRLR
was detected in the Src-/- mice following parturition (Fig-
ure 6B). The level of PRLR mRNA in the mammary gland
of Src-/- mice remained level from P17 through both lac-
tation time points, and then declined at the second day of
involution (I2).
The protein level of PRLR was also increased in Src+/+
mice during lactation compared to the amount of PRLR
protein present at P18 (Figure 6C, top panel, lanes 10–12
and 16–18 compared to 4–6). PRLR protein expression
was only detected in two of the mammary gland lysates
from Src-/- mice (Figure 6C, top panel, lanes 9 and 14).
While two of the protein lysates from Src-/- mice at L2 are
under loaded as indicated by actin loading control (Figure
6C, bottom panel, lanes 7 and 8), analysis of the third
sample suggests that there are lower levels of PRLR protein
at this time point, compared to the samples from Src+/+
mice (Figure 6C, top panel, lane 9 versus 10–12). No
PRLR protein was detected in two of the three Src knock-
out lysates from mice at L9 (Figure 6C, top panel, lanes 13
and 15), while the third Src-/- sample shows diminished
PRLR levels compared to the samples from Src+/+ mice
when then amount of actin present in each sample in
taken into consideration (Figure 6C, top and bottom pan-
els, lane 14 compared to 16–18). Thus, although there is
some animal to animal variation, we conclude that both
PRLR mRNA and protein levels do not increase in Src-/-
mice following parturition. The fact that PRLR mRNA
does not increase following parturition provides further
evidence that secretory activation is altered in Src-/- mice,
as expression of the long form of the PRLR has been
shown to dramatically increase during this transition
[7,8,42].
Prolactin-dependent signaling pathway is diminished in 
Src-/- mice
Downstream components of the prolactin signaling path-
way have also been found to be critical for proliferation
and differentiation of alveoli during pregnancy and for
lactation. Transcription of milk protein genes requires
prolactin-mediated activation of signal transducer and
activation of transcription (STAT)-5 [18,43-45]. Two iso-
forms of STAT5 are known to be expressed in the mam-
mary gland; STAT5a and STAT5b, and both isoforms are
activated by prolactin in the mammary gland and are able
to partially compensate for each other [44]. The levels of
STAT5 are not reported to vary greatly during mammary
gland development, although the tyrosine phosphoryla-
tion of STAT5 increases late in pregnancy and is main-
tained throughout lactation [46]. The phosphorylation of
STAT5 was examined in the mammary glands of Src+/+
and Src-/- mice at P18, L2, and L9, three mice for each
timepoint, by immunoblotting mammary gland lysates
with anti-phospho-STAT5 (tyrosine694) antibody and
anti-STAT5 antibody (Figure 7A). The phosphorylation of
STAT5 was detected at P18 in Src+/+ mice, and phospho-
rylation increased further during lactation; high levels of
phosphorylated STAT5 were observed in all three mice atBMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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Serum prolactin levels are normal in Src knockout mice however, prolactin receptor expression is reduced Figure 6
Serum prolactin levels are normal in Src knockout mice however, prolactin receptor expression is reduced. A) 
Blood was drawn from Src-/-, Src+/- and Src+/+ mice at P17 and L2. Prolactin levels were measured using a radioimmune assay 
and the amount of PRL plotted as the mean (± SEM) of 5 mice for each genotype at the indicated developmental stages. 
Welch's t test was used to evaluate the statistical significance (defined as P < 0.05). Src-/- to Src+/+ at P17 P = 0.26, Src+/- to 
Src+/+ at P17 P = 0.27. Src-/- to Src+/+ at L2 P = 0.89, Src+/- to Src+/+ at L2 P = 0.08. B) Total RNA was isolated from the 
number 4 mammary gland of wildtype and knockout mice at P18, L2, L9, and I 2; three mice were used per genotype and devel-
opmental stage. cDNA was synthesized from 1 μg of total RNA and quantitative RT-PCR was performed using primers and 
probe specific for the long isoform of the prolactin receptor. PRLR message levels were normalized to GAPDH for each sam-
ple and the graph represents the mean (± SEM) relative amount of the triplicate tissue samples. C) The number 4 mammary 
gland was removed from Src-/- and Src+/+ mice at P18 (lanes 1–6), L 2 (lanes 7–12) and L 9 (lanes 13–18). Three separate mice 
were used per genotype and developmental stage. Protein lysates were prepared as described in the Materials and Methods 
sections, and immunoblotting conducted to detect the total amount of PRLR expression (top panel), and the amount of actin, 
as a loading control (bottom panel).BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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Downstream signaling from the prolactin receptor is diminished in Src-/- mice Figure 7
Downstream signaling from the prolactin receptor is diminished in Src-/- mice. A) The number 4 mammary gland 
was removed from Src-/- and Src+/+ mice on day 18 of pregnancy (lanes 1–6), lactation day 2 (lanes 7–12) and lactation day 9 
(lanes 13–18). Three separate mice were used per genotype and developmental stage. Protein lysates were prepared as 
described in the Materials and Methods sections, and immunoblotting conducted to detect phosphorylation of STAT5 (top 
panel), the amount of total STAT5 (middle panel), and the amount of actin, as a loading control (bottom panel). B) Total RNA 
was isolated from the number 4 mammary gland of wildtype and knockout mice on day 18 of pregnancy, lactation days 2 and 9 
and involution day 2, three mice per genotype and developmental stage were used. cDNA was synthesized from 1 μg of total 
RNA and quantitative RT-PCR was performed using primers and probe specific for β-casein. β-casein message levels were nor-
malized to GAPDH for each sample and the graph represents the mean (± SEM) relative amount of the triplicate tissue sam-
ples.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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L2, and in two of the three samples analyzed at L9 (Figure
7A, top panel, lanes 10–12 and 17–18). Based upon the
actin loading control, the total levels of STAT5 in Src+/+
mice did not vary greatly between pregnancy and lactation
(Figure 7A, middle and bottom panels, lanes 4–6, 10–12
and 16–18). Phosphorylation of STAT5 in the Src-/- mice
at L2 and L9 was dramatically reduced compared to
wildtype mice. At P18 the phosphorylation of STAT5 was
evident in only one of the three Src-/- samples at a level
comparable to that detected in the Src+/+ mice (Figure 7A
lane 3 compared to 5–6). During lactation only one of the
analyzed Src-/- samples displayed more than a trace level
of phosphorylated STAT5 signal (Figure 7A lane 9). The
diminished STAT5 tyrosine phosphorylation during lacta-
tion provides further evidence that prolactin signaling is
impaired in Src-/- mice.
The milk protein β-casein is a transcriptional target of
STAT5 downstream of prolactin receptor signaling. In
order to determine if the diminished activation of STAT5
detected in the protein lysates from the Src-/- mice had a
functional consequence upon the expression of milk pro-
tein genes, the levels of β-casein RNA were determined by
quantitative RT-PCR. There was a four-fold increase in the
amount of β-casein RNA between P18 and L9 in the con-
trol mice which is consistent with our findings in others
strains of mice [8,10]. There was an approximate two-fold
increase in the amount of β-casein RNA in the Src-/- mice
between P18 and L9, however, there was as least three-
fold less β-casein RNA in the Src-/- at L9 compared to the
Src+/+ mice (Figure 7B). The amount of β-casein RNA
decreased dramatically with the onset of involution
induced by pup withdrawal.
Src is required for maximal STAT5 activation and β-casein 
expression in cultured primary mammary epithelial cells
To determine whether Src was required for PRL-induced
activation of STAT5 and expression of β-casein we utilized
primary mammary epithelial cells (MECs) isolated from
the mammary glands of Src -/-, Src +/-, and Src +/+ mice.
MECs were cultured on a laminin-rich basement mem-
brane in the absence or presence of PRL, and protein
lysates were harvested after 24 and 72 hours. The expres-
sion and activation of Src in the primary MECs isolated
from each of the three genotypes was determined by west-
ern blotting. Src protein was detected in Src+/+ MECs, and
a reduced level was detected in the Src+/- MECs, indicat-
ing that there was a dose-dependent relationship between
the number of Src alleles and the level of Src protein (Fig-
ure 8A, middle panel, lanes 4–9 and 13–18). No Src pro-
tein was detected in MECs from Src-/- mice (Figure 8A,
middle panel, lanes 1–3 and 10–12). The activation of Src
was examined by anti-phospho-Src (tyrosine416) antibody
and the amount of phosphorylated/activated Src was
found to parallel the amount of Src and not to be depend-
ent upon PRL stimulation (Figure 8A, top panel, lanes 4–9
and 13–18). We hypothesize that PRL-dependent Src acti-
vation could not be detected in the Src+/+ and Src+/-
MECs due to the high basal levels of Src phosphorylation
that may result from activation of integrin signaling stim-
ulated by attachment to the laminin-rich basement mem-
brane and the presence of insulin in the differentiation
medium. Very little immunoreactive protein was detected
with the anti-phospho-Src antibody in Src-/- MECs (Fig-
ure 8A, top panel, lanes 1–3 and 10–12), which con-
trasted with the results obtained in studies of whole
mammary gland lysates from Src-/- mice (Figure 2).
PRL-dependent phosphorylation/activation of STAT5 was
detected in the MECs isolated from each of the three gen-
otypes of mice (Figure 8B, top panel, lanes 1–18). The
level of phosphorylated STAT5 detected in Src-/- MECs
was diminished compared to that observed in wild type
MECs 24 hours following PRL stimulation, and this
decrease was even more evident after 72 hours of stimula-
tion with PRL (Figure 8B, top panel, lanes 2–3 compared
to 8–9 and lanes 11–12 compared to 17–18, respectively).
The amount of β-casein protein expressed by Src-/- MECs
was dramatically reduced compared to the level present in
Src+/+ MECs following both 24 and 72 hours of differen-
tiation with PRL (Figure 8C, top panel, lanes 2–3 com-
pared to 8–9 and lanes 11–12 compared to 17–18). The
levels of Raf and ERK 1/2 were used to demonstrate equal
loading of samples. The level of β-casein protein in MECs
isolated from Src+/- mice was intermediate, possibly
reflecting a dose-dependent affect of Src upon either the
transcription or translation of β-casein (Figure 8C, top
panel, lanes 5–6 and 14–15). These data clearly demon-
strate that Src has a primary role in PRL-dependent expres-
sion of milk protein genes such as β-casein in primary
MECs, and demonstrate that this effect can be separated
from possible systemic effects of Src in vivo.
Involution is accelerated in Src-/- mice
Following weaning of the pups, the mammary gland
undergoes involution; a process during which approxi-
mately 80% of the mammary epithelial cells present in the
lactating mammary gland undergo apoptosis and the
entire mammary gland is remodeled back to a pubertal-
like morphology [47,48]. Due to the difficulty of timing
specific biochemical events during natural involution,
involution is experimentally induced by withdrawal of
pups from a lactating dam. Although involution induced
by pup withdrawal results in a process that is significantly
different on the molecular level from that which occurs
following natural weaning [49], it does result in a series of
reproducible and well-defined histological and biochem-
ical changes [47,49]. Pups were withdrawn after L9 from
Src+/+ and Src-/- dams to induce involution. The first day
following pup withdrawal is referred to involution day 1BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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Primary mammary epithelial cell cultures confirm that Src is required for maximal prolactin signaling Figure 8
Primary mammary epithelial cell cultures confirm that Src is required for maximal prolactin signaling. Primary 
mammary epithelial cells isolated from Src-/- (lanes 1–3 and 10–12), Src+/- (lanes 4–6 and 13–15) and Src+/+ (lanes 7–9 and 
16–18) mice were cultured on Matrigel in growth medium for 3 days then the medium was changed to differentiation medium 
and the cells were cultured for a further 24 or 72 hours in the presence or absence of prolactin. Cellular proteins were 
extracted by lysis in NET buffer. A) Immunoblotting was performed to detect phosphorylation of Src (tyrosine416) (top panel), 
total levels of Src protein (middle panel) and the amount of ERK 1&2 (bottom panel) as a loading control. B) Immunoblotting 
was performed to detect phosphorylation of STAT5 (tyrosine694) (top panel), total levels of STAT5 (middle panel) and the 
amount of ERK 1&2 (bottom panel) as a loading control. C) Immunoblotting was performed to detect β-casein expression (top 
panel), the levels of Raf and the amount of ERK 1&2 as loading controls (middle and bottom panels).BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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(I1). Twenty four hours after pup withdrawal (I1), secre-
tory alveoli were still present in the mammary glands of
Src+/+ mice (Figure 9, panel A). By I2 secretory alveoli
were distended and mammary adipocytes could be
observed in the Src+/+ mice (Figure 9, panel B). Collapse
of the lobular alveolar units, numerous mammary adi-
pocytes, and distended ducts were clearly present in the
mammary glands of control Src+/+ mice by I4 (Figure 9,
panel C). The remodeling of the mammary gland contin-
ued after this point and was largely complete by I8 in the
Src+/+ mice (Figure 5, panel E). In contrast the sequence
of events observed in the mammary glands of Src-/- mice
was distinctly different; the histology of the mammary
gland twenty four hours after pup withdrawal resembled
the morphology of the I8 mammary gland in Src+/+ mice
(Figure 9, compare panel G with panel E). Thus it appears
that involution is dramatically accelerated in Src-/- mice,
and may reflect the apparent failed secretory activation
and the precocious involution that appears to occur in Src-
/- dams even when pups are suckling and should be pro-
viding a stimulus for lactation and survival of mammary
epithelial cells (see Figure 4, panels D and E).
There are many biochemical markers that define mam-
mary gland involution including activation of STAT3 [50],
changes in the expression of Bcl2 family members [51-
53], and activation of matrix metalloproteases [54]. We
examined the expression and phosphorylation/activation
of STAT3 as a marker of involution since STAT3 is acti-
vated early during involution and conditional tissue-spe-
cific deletion of STAT3 results in delayed involution
[50,55]. Activation of STAT3 was detected in all three of
the Src knockout mammary gland lysates isolated on day
two of lactation (Figure 10A top panel, lanes 1–3), and
one of the three Src-/- mice analyzed on day L9 (Figure
10A, lane 9). There was no phosphorylation/activation of
STAT3 on either L2 or L9 in the Src+/+ mice, even though
the total levels of STAT3 expression were comparable to
those in the Src-/- mice (Figure 10A, top panel, lanes 4–6
and middle panel, compare lanes 4–6 to lanes 1–3). These
data provide additional evidence for precocious involu-
tion occurring in the Src-/- mice, perhaps as a result of the
failed secretory activation described above.
As a second marker for involution, we examined the acti-
vation of matrix metalloproteases in the mammary glands
of both Src+/+ and Src-/- mice using a gelatinase assay in
which the ability of MMP2 to degrade gelatin in a sub-
strate gel is examined. Bands with molecular weights of 72
kDa and 62 kDa were observed (Figure 10B); the 72 kDa
molecular weight band corresponds to the proenzyme of
MMP2 and the 62 kDa molecular weight band corre-
sponds to the activated form of MMP2. Consistent with
previous results, the 62 kDa molecular weight band can
start to be detected at I2 and is prominent by I4, I6 and I8
in the wild type mice (Figure 10B, top panel). In contrast,
the 62 kDa molecular band was readily detected in mam-
mary glands of Src-/- mice at L9 and I1, and was present at
Involution is accelerated in mammary glands from Src-/- mice Figure 9
Involution is accelerated in mammary glands from Src-/- mice. Histological sections from the mammary glands of 
Src+/+ (A-F) and Src-/- (G-L) mice are shown at I 1 (A, G), I2 (B, H), I4 (C, I), I6 (D, J), I8 (E, K) and I14 (F, L). Scale bars rep-
resent 250 μm.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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maximal levels by I2 and I4. (Figure 10B, bottom panel).
Minimal levels of either form were present from I6 to I14
in the mammary gland from Src-/- mice. This provides fur-
ther evidence that involution occurs precociously in the
mammary glands of Src-/- mice.
Discussion
The members of the Src family of protein tyrosine kinases
are activated by a wide variety of stimuli including recep-
tors for peptide growth factors, steroid hormone recep-
tors, immune receptors, and integrin molecules. Because
all of these receptors are important in different phases of
mammary gland development, we were interested in
exploring whether Src-like kinases mediated the down-
stream signaling events required for a functional mam-
mary gland. Src, Fyn and Yes are widely expressed in
different tissues, while the remaining family members
(Blk, Hck, Fgr, Lyn, and Lck) are expressed in one or more
lineages of hematopoietic cells [21,56]. We focused upon
Src and Fyn in our studies because they are the major Src
family members expressed at detectable levels during
mammary gland development [33,57], and the low levels
of the remaining Src family members could represent
expression in infiltrating hematopoietic cells. Src-/- mice
have osteopetrosis which results in thick bones and an
altered shape to the skull. These changes result from a
defect in bone-remodeling that is caused by nonfunc-
tional osteoclasts [58]. Src-/- mice also lack teeth and were
reported to be profoundly smaller by 10–12 days after
birth [58]. Soriano et al reported that most of the mice die
at 3–4 weeks if weaned, although a small number of mice
could be maintained past five weeks if fed a soft diet [58].
Replacement of rodent chow with a liquid diet allows
growth to a normal size and long-term survival.
We and others have described that Src is required for duc-
tal elongation during puberty in Src-/- mice. Kim et al
have suggested that this defect is due to diminished estro-
gen receptor signaling in the mammary gland [31], while
we hypothesize that expression of Src is required in the
stromal cell compartment (Richert et al, unpublished
data). The data presented in this manuscript describe a
novel role for Src in the mammary gland during secretory
activation and/or lactation that was not previously antici-
pated by the phenotype of the Src knockout mice. We
have observed that the growth of pups nursed by Src-/-
dams is severely diminished and over 80% of the litters do
not survive more than a few days. This phenotype is deter-
mined by the genotype of the dam and not the pups such
that the growth of FVB, C57Bl6 and Src+/- pups nursed by
Src-/- dams was diminished. The fact that over 90% of
pups born to Src-/- mothers die within days, and that over
80% of fostered litters also die, indicates that a failed lac-
tation is the predominant phenotype. The variation in the
histology of the lactating mammary gland may reflect a
physiological state in which survival of mammary epithe-
lial cells is supported even when lactation is compro-
mised. Analysis of the mammary gland of Src-/- mice
during pregnancy and lactation reveals that large CLDs
accumulate in the MECs of Src-/- mice following parturi-
tion providing evidence that secretory activation has not
occurred [10]. Serum PRL levels in the Src-/- mice are nor-
mal indicating that neuronal stimulation of the hypotha-
lamus, release of prolactin releasing factor, the response of
the pituitary to this stimulus and hormonal signals from
the pituitary are not affected by the absence of Src. We
have demonstrated by gene expression profiling that
expression of the long form of the PRLR increases at par-
turition in the mammary gland of normal mice [7,8],
which is in agreement with other data using PCR-based
approaches [42], however it appears that expression of the
PRLR is diminished, although not absent, in the mam-
mary glands of Src-/- mice (Figure 11). The decreased
Precocious activation of STAT3 and activation of MMP2 sug- gest early onset of involution Figure 10
Precocious activation of STAT3 and activation of 
MMP2 suggest early onset of involution. A) The 
number 4 mammary gland was removed from Src-/- and 
Src+/+ mice at P18 (lanes 1–6), L2 (lanes 7–12) and L9 (lanes 
13–18). Three separate mice were used per genotype and 
developmental stage. Protein lysates were prepared as 
described in the Materials and Methods sections, and immu-
noblotting conducted to detect phosphorylated STAT3 
(tyrosine7705) (top panel), the total amount of STAT3 
expression (middle panel), and the amount of ERK 1&2 as a 
loading control (bottom panel). B) Mammary gland lysates 
were prepared from Src+/+ (top panel) and Src-/- (bottom 
panel) mice at L9. I1, I2, I4, I6, I8, and I14. The positions of 
the 72 kDa molecular weight proenzyme and 62 kDa molec-
ular weight active enzyme are indicated on the left side of the 
panels.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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expression of the PRLR in the Src-/- mice can thus account
for the diminished activation of the STAT5 transcription
factor, which regulates expression of milk protein genes.
The impaired lactation we have observed in the Src-/- mice
shares some features with those observed in the PRLR
knockout mice described by Ormandy et al [59]. While is
not surprising that the PRLR-/- mice exhibit severely
diminished lobuloalveolar development during preg-
nancy and a complete failure of lactation, it was unex-
pected that young PRLR+/- mice also exhibit severely
diminished lactation since these mice still have one func-
tional PRLR allele. Lactation failure only occurs after the
first pregnancy of young PRLR+/- mice however, and the
success of lactation in PRLR+/- mice improves as the
number of pregnancies increases or if the mice are older at
the time of first pregnancy [59]. This implies that there is
an important effect of the level of PRLR expression upon
mammary gland development either late in pregnancy or
during secretory activation. In the PRLR+/- mice this is
manifested by the lactation failure at first pregnancy that
is offset by further mammary gland development that
occurs as the mouse ages such that older PRLR+/- mice
successfully lactate. Thus the phenotype we have observed
in the Src-/- mice may be directly related to the level of
PRLR expressed at secretory activation.
As noted in the introduction, we have identified four
potential regulatory genes whose expression dramatically
increases at secretory activation: PRLR, Src, Akt, and
SREBP1c [7,8]. In light of these observations, it is interest-
ing to note that in the absence of Src, the increase in the
Model of the pathways required for secretory activation and lactation that are perturbed in Src-/- mice Figure 11
Model of the pathways required for secretory activation and lactation that are perturbed in Src-/- mice. A) 
PRLR EXPRESSION. In normal mice PRLR expression increases at parturition, this is absent in the Src-/- mice and they have 
decreased levels of both PRLR message and protein. B) INTEGRIN CROSSTALK. Integrin-mediated adhesion is essential for 
STAT5 activation downstream of PRLR signaling and Src may be a required mediator for the β 1 integrin-induced crosstalk. 
The Src-/- mice have diminished levels of STAT5 phosphorylation. C) POLARITY. Epithelial cell polarity is crucial for secretory 
activation. The mammary glands of Src-/- mice do not have organized lobuloalveolar structures and many of the epithelial cells 
do not show restricted apical staining suggesting that Src is required for epithelial cell polarity and organization. D) MILK PRO-
TEIN TRANSCRIPTION. Src-/- mice have significantly less β-casein message compared to wildtype mice. This may be directly 
related to the decreased levels of STAT5 activation in these cells or Src may also be a required signaling molecule in the addi-
tional pathways necessary for milk protein transcription. E) MILK PROTEIN TRANSLATION. Milk protein expression is also 
regulated at the translational level. Src-/- mice have decreased levels of milk proteins and a possible role for Src in the post-
transcriptional regulation has not been investigated.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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expression of the long form of the PRLR at secretory acti-
vation does not occur in Src-/- mice as observed in
wildtype mice, suggesting that Src is required for optimal
PRLR expression in the mammary gland during the transi-
tion from pregnancy to lactation (Figure 11, panel A).
Because the expected increase in PRLR expression and
milk protein genes does not happen in the Src-/- mice we
believe that secretory activation has not occurred. A recent
study suggests that Akt1 plays a critical role in lactation,
perhaps by regulating the levels and plasma membrane
localization of GLUT1, as well as the levels of lipogenic
enzymes whose expression are regulated by SREBP1 [60].
We have not examined whether the expression levels of
either Akt or SREBP-1c are altered in the mammary gland
of Src-/- mice.
As a means to confirm our in vivo observations, we chose
to examine the differentiation of primary MECs estab-
lished from Src+/+, Src+/-, and Src-/- mice. MECs were
established from adult virgin mice following injection
with progesterone and estradiol for 21 days to stimulate
proliferation and differentiation of these cells. We used
this approach because it allowed expansion of the epithe-
lial cell compartment of the mammary gland in the
absence of pregnancy which might have presented addi-
tional complications to the experimental design. MECs
were plated on Matrigel, induced to differentiate follow-
ing stimulation with PRL, and differentiation monitored
by the expression of β-casein protein. At early time points
after differentiation with PRL, the activation of STAT5 was
lower in cultures of Src-/- MECs than in Src+/- or Src+/+
MECs, and the amount of β-casein protein was lower in
Src-/- and Src+/- cells compared to Src+/+ MECs. There is
an apparent dose-dependent effect on the amount of β-
casein expressed in the cells with regard to the expression
of Src. We have not detected a difference in the amount of
PRLR in cultures of primary MECs from Src-/- mice com-
pared to wildtype mice and thus suggest that there is an
effect of Src upon either the transcription and/or transla-
tion of β-casein and by extension other milk protein genes
(Figure 11, panels D and E).
A possible mechanism by which Src might regulate
expression of β-casein is suggested by the observations of
Streuli and his colleagues who have demonstrated a role
for the cytoskeleton in PRL-dependent differentiation of
MECs and that activation of STAT5 occurs in a integrin-
dependent manner (Figure 11, panel B) [61-63]. Binding
of integrins to extracellular matrix or peptide ligands leads
to activation of focal adhesion kinase (FAK) [64-67]. Src is
associated with FAK and Src phosphorylates FAK on at
least one site that may regulate activation of downstream
signaling molecules including phosphatidylinositol 3'-
kinase [68-71]. In spite of the known association of Src
with FAK and the ability of Src to phosphorylate FAK, we
have not detected a decrease in tyrosine phosphorylation
of FAK at site favored by Src in the Src-/- MECs implying
that other tyrosine kinases are able to phosphorylate this
site in these cells (H. Watkin and S.M. Anderson, data not
shown). This also suggests that while Src may be an inter-
mediate in the pathway by which integrins regulate milk
protein gene expression, it is likely that the Src-mediated
phosphorylation of FAK is not the means by which this
occurs. The recent suggestion that Rac1 links integrins to
lactational differentiation [62] causes us to wonder
whether Src lies upstream, downstream, or is independent
of Rac1.
The disorganized luminal structure of secretory alveoli in
Src-/- mice also suggests an important role for Src in estab-
lishing the polarity of epithelial cells. Src family kinases
have previously been implicated in both positive and neg-
ative regulation of epithelial tight junction assembly and
polarization. Src-dependent phosphorylation of Par3
downstream of EGF receptor activation is required for
tight junction formation [72]; however it has also been
suggested that ErbB2-dependent activation of Src results
in disruption of epithelial cell-cell contacts [73], thus
highlighting the multiple roles of Src within a cell and the
different effects that depend on upstream signals and cel-
lular context. In the case of normal mammary gland
development, it appears that Src plays a positive role with
regard to the structural organization of the secretory epi-
thelial cells within alveoli and the polarity of these cells
(Figure 11, panel C).
Additionally, several links have been reported between
the activity of Src kinase and Rho GTPases. The small
GTPases of the Rho family regulate many cellular func-
tions including cell adhesion, migration and cell-cell junc-
tions [74]. Src is involved in the activation of Rac [75] and
Cdc42 [76] and can inhibit Rho [77,78]. In the mammary
gland Rac1 has been found to be required for lactational
differentiation in a primary cell culture model [79].
Whilst we have not investigated the activation of Rac1 in
the mammary glands of Src-/- mice this may be another
pathway that could be perturbed by a lack of Src. PKN1
transgenic mice are another mouse model that display
impaired secretory activation [80]. The expression of a
constitutively activated form of the Rho effector protein
PKN1 results in impaired tight junction sealing. This
implies that Rho negatively regulates tight junction clo-
sure. The possible requirement for Src to down regulate
Rho is an additional mechanism by which Src may regu-
late secretory activation. Whilst we have observed disor-
ganized alveolar structures in the Src-/- mice we have not
established which of the many pathways that regulate
tight junction formation, cell polarization, and differenti-
ation are perturbed by the lack of Src in mammary epithe-
lial cells.BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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Secretory activation occurs at parturition and is required
for lactation. While the mechanisms underlying secretory
activation remain unknown, we have noted that there are
four signaling molecules/transcription factors whose
expression is increased at this time; PRLR, Src, Akt1, and
SREBP1c [7,8]. Secretory activation requires the coordi-
nate increase in the expression of milk protein genes as
well as the genes that are required for the synthesis of the
lipid component present in milk. When the pattern of
expression of milk proteins genes is closely examined, it
becomes apparent that there are actually two different
classes of milk proteins genes; the level of the casein-like
class increases over the course of pregnancy and then
undergoes a further three-fold increase at secretory activa-
tion (α-casein, β-casein, δ-casein, κ-casein, whey acidic,
and ADPH), while the second does not increase during
pregnancy and the RNA level only increases at secretory
activation (δ-casein,  α-lactalbumin, MUC1, xanthine
oxide dehydrogenase, and butyrophilin) [10]. The fact
that we are able to detect β-casein RNA at P18 suggests to
us that the increase in milk proteins genes in the early-
expressed class, referred to as the casein-like genes above,
occurs in the Src-/- mice, however the second increase in
expression that occurs at secretory activation does not
occur. This is re-enforced by the fact that there is no
increase in the amount of β-casein RNA between P18 and
L2 in the Src-/- as observed in the Src+/+ control mice. We
have recently noted that expression of lipogenic enzymes
increases dramatically at secretory activation [7,8], and it
would be of great interest to determine whether expres-
sion of these genes is altered in Src-/- mice. The fact that
large CLDs are observed in the mammary glands from Src-
/- mice clearly indicates that lipid biosynthesis during
pregnancy is normal; however, it is not clear whether it
increases following parturition.
The mammary glands of Src-/- mice undergo precious
involution, as demonstrated by histology and biochemi-
cal markers. The decisive trigger for the onset of involu-
tion and apoptosis of the epithelial cells within the
mammary gland is unknown, however a number of mol-
ecules and stimuli have been shown to play a role. These
include milk stasis, leukemia inhibitory factor, STAT3
activation, interleukin 6, Fas ligand, loss of integrin acti-
vation, transforming growth factor-β 3 and insulin-like
growth factor-binding protein 5 [81-87]. Lactation failure
has been observed in the mammary glands of several
other transgenic mice, including models with impaired
tight junction sealing and another in which the milk has a
high fat content which may result in milk stasis due to the
inability of pups to remove milk from the mammary
gland [80,88]; in both of these models lactation failure
leads to activation of a precocious involution program.
The lactation failure observed in the Src-/- mice may result
in a dominant signal that results in precocious involution
and thus it is not possible to determine whether Src is
required for survival of mammary epithelial cells. The fact
that increased apoptosis was not observed in primary
mammary epithelial cells from Src-/- mice, and the fact
that mammary epithelial cells proliferate during preg-
nancy suggest that Src may not be required for cell survival
although we have not directly tested this possibility.
Our studies indicate a new role for Src that had not been
anticipated based upon previous studies of Src-/- mice, or
the study of mammary gland development using either in
vivo or in vitro systems. The role for Src in secretory activa-
tion and lactation is apparently unique to Src as we have
not observed this phenotype in Fyn-/- mice. The lactation
failure in the Src-/- mice demonstrates that other Src fam-
ily members are not able to compensate for the loss of Src.
Given the number of different regulatory pathways acti-
vated in secretory activation, which includes both Akt1
and SREBP1, it will be of great interest to determine
whether expression of any of the regulatory molecules
that lie downstream of the PRLR is able to compensate for
the loss of Src in secretory activation. We would anticipate
that expression of some might complement the loss of Src
in stimulating expression of milk protein genes in MECs,
while other molecules might be required to complement
the loss of Src in vivo. Expression of constitutively acti-
vated signaling molecules in vitro and in the mammary
gland in vivo, via either the use of recombinant human
adenoviruses or expression of transgenes in the mammary
gland will provide additional insights into the multiple
actions of Src in this tissue.
Conclusion
Src is essential in the mammary gland for successful lacta-
tion as Src-/- mice are unable to support the growth, and
often the survival, of their pups. Histological analysis of
mammary glands from late pregnant and post-partum
Src-/- mice suggests that Src-/- mice fail to undergo secre-
tory activation. The precise mechanisms by which secre-
tory activation are controlled are not yet fully understood,
however we have studied some of the known critical fac-
tors in order to investigate the role of Src, summarized in
Figure 11. Src is required for an increase in PRLR expres-
sion and may also be required for the crosstalk from
integrin signaling that is essential for signal propagation
down-stream of the PRLR (Figure 11, panels A and B).
Tight junction closure is a hallmark of secretory activation
and epithelial polarity is essential for lactation. The disor-
ganized luminal structure of secretory alveoli in Src-/-
mice suggest an important role for Src in establishing the
polarity of epithelial cells (Figure 11, panel C). Src-/- mice
also have decreased levels of β-casein message (Figure 11,
panels D and E). In vitro studies conducted on MEC from
Src-/- mice suggest a primary role for Src in regulating
either the transcription or translation of milk proteinBMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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genes that may be distinct from its role in secretory activa-
tion.
Methods
Mice
Src-/- [58] mice were obtained from Dr. Paul Stein
(Northwestern University School of Medicine, Chicago,
IL). The knockout line is on a mixed 129Sv × C57Bl6
background, with approximately 75% of the alleles being
of C57Bl6 (Personal communication, Paul Stein). Thus
Src-/- and Src+/- mice are mixed C57Bl6 and 129Sv. The
Src-/- mice lack teeth [58] and therefore were fed Liquid
Rat Diet (Bio-Serv, Frenchtown, NJ; Product #F1259SP)
and water ad librium. All mice were maintained on a nor-
mal 12-hour day/night cycle. Control, Src+/+ F1(C57Bl6
× 129Sv) and F2 [C57Bl × F1(C57Bl6 × 129Sv)] mice were
either obtained from The Jackson Laboratory (Bar Harbor,
ME), or were generated in-house. All mice were main-
tained in the Animal Care Facilities at the University of
Colorado Health Sciences Center, an AAALAC-approved
facility, and used in accordance with institutional ACUC-
approved protocols. DNA was extracted from 1.5 cm sec-
tions of tails using the Puregene DNA Purification Kit
(Gentra Systems, Minneapolis, MN) according to the
manufacturer's directions or using a protocol described
previously [89], with the modification that one phe-
nol:chloroform:isoamyl alcohol (25:24:1) extraction was
performed prior to ethanol precipitation. DNA pellet was
resuspended in TE (10 mM Tris, pH 8.0, 1 mM EDTA).
Genotyping of Src-/- mice utilized the following primers:
NeoSrc, 5'-TCATAGCCGAATAGCCTCTCCAC-3'; forward
Src primer, 5'-AGCAACAAGAGCAAGCCCAAGGAC-3',
and reverse Src primer, 5'-GTGACGGTGTCCGAGGAGTT-
GAAG-3'. One microgram of DNA was amplified by PCR
using primers (50 pmol/reaction) described above: 95°C
for 10 min; 30 cycles of 94°C for 1.5 min, 60°C for 1.5
min, and 72°C for 1.5 min; followed by a 10 min exten-
sion time at 72°C. This reaction produces a 200 base pair
product from the wildtype Src allele and a 400 base pair
fragment from the rearranged Src allele.
Immunoblot analysis
The fourth inguinal mammary gland was removed at the
indicated developmental stage and snap frozen in liquid
nitrogen. The gland was ground in liquid nitrogen with a
pestle and mortar then proteins were extracted by homog-
enizing in lysis buffer [(50 mM Tris pH 7.4, 150 mM
NaCl, 2 mM EDTA, 50 mM NaF, 1% Triton X-100, 1%
DOC, 0.1% SDS, 1 mM DTT, 5 mM sodium orthovanad-
ate, 100 μg/ml PMSF, and a protease inhibitor cocktail
(Sigma # P 8340, St. Louis, MO)]. Homogenates were cen-
trifuged at 13,000 × g for 30 min at 4°C. Soluble fractions
were stored at -80°C. Protein assays were performed using
the Pierce Coomassie Plus protein assay reagent (Pierce
Chemical Company, Rockford, IL). 50–100 μg amounts
of total protein were resolved on SDS-polyacrylamide
gels, transferred to polyvinylidene difluoride (PVDF)
membrane (Immobilon, Millipore, Bedford, MA), and
immunoblotted with the desired antibody. Bound anti-
bodies were detected using ECL according to manufac-
turer's recommendations (Western Lighting Perkin Elmer,
Boston, MA). Anti-Src monoclonal antibodies 327 and
2–17 were prepared in house. Rabbit anti-STAT3 (SC-
482), rabbit anti-ERK (SC-93), rabbit anti-STAT5A (SC-
1081), rabbit anti-Raf (SC-133), rabbit anti-prolactin
receptor (SC-20992), and HRP-conjugated rabbit anti-
actin (SC-1616) antibodies were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-phos-
pho-Src (Tyrosine416; Cat # 2101), rabbit anti-phospho-
STAT5 (Tyrosine694; Cat # 9351), and rabbit anti-phos-
pho-STAT3 (Tyrosine705; Cat#9131) antibodies were
obtained from Cell Signaling Technology (Beverly, MA). A
rabbit polyclonal antiserum raised against mouse milk-
specific proteins (Cat # YNRMTM) was obtained from
Accurate Chemical and Scientific Corp. A rabbit anti β-
casein antibody was obtained from Margaret C. Neville
(University of Colorado Health Sciences Center). HRP-
conjugated Anti-rabbit and Anti-mouse secondary anti-
bodies were from Bio-Rad (Cat # 170-6515 and Cat # 170-
6516 respectively).
Preparation of mammary gland whole-mounts and thin 
sections for histological evaluation
The second and third thoracic and fourth inguinal mam-
mary glands of control and transgenic mice were dissected
on days 6, 12, and 18 of pregnancy (P6, P12, P18); days 2
and 9 of lactation (L2, L9); and days 1, 2, 4, 6, 8, and 14
of involution (I1, I2, I4, I6, I8, I14). Pregnancy time
points indicate the number of days after the formation of
vaginal plugs upon mating. Lactation time points imply
the number of days the female lactated after parturition
(postpartum days), and the number of pups per litter was
normalized to eight by the addition of same-age pups
from control litters. For involution time points, pups were
removed on the 9th day postpartum to induce forced invo-
lution.
Whole-mount analysis of dissected mammary glands was
preformed as described previously [57,90,91].
For histological analysis, dissected mammary glands were
fixed in 10% neutral buffered formalin, embedded in par-
affin, sectioned (4 μm), and stained with hematoxylin
and eosin. Histological sectioning and staining was per-
formed by the Histology Service, Department of Pathol-
ogy, University of Colorado School of Medicine.
Immunofluorescence and lipid droplet analysis
Mammary glands were dissected at the indicated develop-
mental stages, fixed in 10% neutral buffered formalin,BMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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and embedded in paraffin. Sections were cut at 5 microns.
Following dehydration with graded alcohols, microwave
antigen retrieval was performed for 20 min in 10 mM
sodium citrate, pH 6.0. The sections were permeabilized
with 0.2% Triton X-100 in PBS, blocked with 5% goat
serum in PBS, and incubated with a rabbit polyclonal
anti-adipophilin antibody (ADRP; also known as adi-
pocyte differentiation-regulated protein) (Dr. Thomas
Keenan, Virginia Polytechnic Institute and State Univer-
sity, Blacksburg, VA) at a dilution of 1:200. The sections
were then incubated with Cy3-conjugated anti-rabbit IgG
(Jackson ImmunoReasearch Laboratories, Inc, West
Grove, PA) at a 1:150 dilution, Oregon-Green 488-conju-
gated wheat germ agglutinin (WGA) (Molecular Probes,
Eugene, OR) at a 1:250 dilution and 0.6 μg/ml DAPI
(Sigma). Images were collected using SlideBook software
(Intelligent Imaging Innovations, Inc, Denver, CO) on a
Nikon Diaphot TMD microscope equipped for fluores-
cence with a Xenon lamp and filter wheels (Shutter Instru-
ments, Novato, CA), cooled CCD camera (Cooke,
Tonawanda, NY) and stepper motor (Intelligent Imaging
Innovations, Inc).
Quantitation of serum prolactin levels
Blood was collected from five Src-/-, five Src+/-, and five
Src+/+ mice on day seventeen of pregnancy and day two
of lactation, and plasma prepared. Quantitation of prolac-
tin levels in the plasma was conducted using a radio-
immune assay by Dr. A. F. Parlow of the National Hor-
mone and Peptide Program, UCLA Medical Center, Tor-
rance, CA.
Measurement of Pup Weights
As a means to assess the efficiency of lactation in Src-/-
dams the weights of fostered pups nursed by Src -/- dams
were compared to the weights of pups nursed by control
FVB, C57Bl6 and Src+/- dams. Litters were normalized to
8 pups and the whole litter was weighed daily. The average
pup weight was calculated by dividing the whole litter
weight by the number of pups weighed (eight). The litters
of the Src-/- dams were replaced with control FVB pups of
the same age on the first day postpartum and fostered pup
weights were recorded for 9 days of lactation. In addition
to fostering new born litters older, more experienced
C57Bl6 or Src+/- pups were also used to assess lactational
competency. For the control experiments litters of three
individual dams were recorded and the error bars depict
the s.e.m. of the average pup weight in each of those con-
trol litters.
Quantitative RT-PCR analysis
The fourth inguinal mammary gland was removed at the
developmental stage indicated and stored in RNA later
(QIAGEN) according to the protocol. Total RNA was pre-
pared using the RNeasy Mini Kit (QIAGEN) and RNA
integrity analyzed by RNA 6000 Nano Assay (Agilent
Technologies, Palo Alto, CA). 1 μg RNA was reverse tran-
scribed using a mix of random hexamers and oligo dT
primers and SuperScript III RT (Invitrogen). PCR primer
and probe sets were designed using TaqMan Primer
Express™ software to target a splice boundary within a
message sequence to avoid the amplification of genomic
DNA. All primers, labeled probes and synthetic amplicon
sequences were purchased from either Applied Biosystems
or Integrated DNA Technologies. RT-PCRs were per-
formed using an Opticon Monitor II RT-PCR detection
system plus the accompanying software version 2.02.24
(MJ Research, Bio-Rad Laboratories, Inc., Hercules, CA).
Copy numbers of the investigated genes were calculated
from the respective standard curves, which were generated
with amplicons, using the formula 10^[(Ct-Y intercept)/
(slope)]. For each sample the ratio of the copy number of
the investigated gene to the copy number of GAPDH pro-
duced normalized data. Welch's t test was used to evaluate
the statistical significance (defined as P < 0.05).
Preparation of primary mammary epithelial cells and in 
vitro differentiation
Mammary epithelial cells (MECs) are traditionally pre-
pared from the mammary glands of four to six late preg-
nant mice that are 10–12 weeks old. Because of the
difficulty in obtaining multiple Src-/- mice that were
impregnated within a narrow window of time to allow the
preparation of MECs from late pregnant mice, we chose to
inject eight- to ten-week old virgin Src+/+, Src+/-, and Src-
/- mice with 1 mg progesterone and 1 μg estradiol daily for
21 days, six mice of each genotype were used for each
preparation of MECs. All of the mammary glands were
removed, and the surrounding tissue and inguinal lymph
nodes removed to minimize contamination of the cul-
tures. MECs were prepared as described by Pullan and
Strueli [92]. The isolated aggregates of mammary orga-
noids were washed 3× in F12 medium to remove single
cells such as fibroblasts. The primary MECs were cultured
on Matrigel-coated dishes in growth medium (50%
DMEM with glutamine, 50% F12 with glutamine, 10 mM
HEPES, 10% Fetal calf serum, 5 μg/ml insulin, 1 μg/ml
hydrocortisone, and 10 ng/ml recombinant epidermal
growth factor with penicillin and streptomycin), for 72
hours. Differentiation of MECs was induced by changing
the culture medium to differentiation medium (DMEM
with glutamine, 10 mM HEPES, 5 μg/ml insulin, 1 μg/ml
hydrocortisone, with penicillin and streptomycin). The
cells were cultured in this medium in the presence or
absence of 3 μg/ml ovine prolactin for 24 or 72 hours
before lysis in 2 × NET buffer (100 mM Tris pH 7.4, 300
mM NaCl, 10 mM EDTA, 2% Nonidet®-P40, supple-
mented with freshly added phosphatase inhibitors 100
mM NaF, 10 mM sodium orthovanadate, and a protease
inhibitor cocktail (Roche Diagnostics Gmbh CompleteBMC Developmental Biology 2008, 8:6 http://www.biomedcentral.com/1471-213X/8/6
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EDTA-free cat # 11 873). Homogenates were centrifuged
at 13,000 × g for 30 min at 4°C and immunoblot analysis
performed as described above.
Zymogram gels
The samples to be analyzed were prepared from frozen tis-
sue in mammary gland extraction buffer and protein con-
centrations quantified as described above. 30 μg of total
protein was diluted in SDS sample buffer lacking β-mer-
captoethanol and was not heat denatured prior to load-
ing. Samples were separated on a 7.5% SDS gel containing
3 mg/ml of type A porcine gelatin (Sigma Aldrich, cat. #G-
2500). The gels were run at 60 V for 30–45 min through
the stacking gel and then at 120 V until the samples
reached the bottom of the running gel. The gels were
washed twice for 30 minutes in 2.5% Triton X-100 at
room temperature while rocking. The gels were then incu-
bated on a rocking platform at 37°C for 24–72 hours in
substrate buffer (50 mM Tris-HCl, pH 8.0; 5 mM CaCl2).
The gels were stained for one hour at room temperature
with 0.25% Coomassie Brilliant Blue-R, and destained
overnight in water.
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